📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Low-dose i nterleukin 2 for the reduction of v ascular inflammati o n in acute corona ry syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial (2022)

First Author: Sriranjan R

Attributed to: Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-062602

PubMed Identifier: 36207050

Publication URI: http://europepmc.org/abstract/MED/36207050

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 10

ISSN: 2044-6055